Literature DB >> 26573416

Litomosoides sigmodontis: a jird urine metabolome study.

Daniel Globisch1, Sabine Specht2, Kenneth M Pfarr2, Lisa M Eubanks1, Achim Hoerauf2, Kim D Janda3.   

Abstract

The neglected tropical disease onchocerciasis affects more than 35 million people worldwide with over 95% in Africa. Disease infection initiates from the filarial parasitic nematode Onchocerca volvulus, which is transmitted by the blackfly vector Simulium sp. carrying infectious L3 larvae. New treatments and diagnostics are required to eradicate this parasitic disease. Herein, we describe that a previously discovered biomarker for onchocerciasis, N-acetyltyramine-O-glucuronide (NATOG) is also present in urine samples of jirds infected with the onchocerciasis model nematode Litomosoides sigmodontis. Increased NATOG values paralleled a progressing infection and demonstrated that quantification of NATOG in this rodent model can be utilized to track its infectivity. Moreover, our findings suggest how NATOG monitoring may be used for evaluating potential drug candidates.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Litomosoides sigmodontis; Metabolomics; Neurotransmitter; Onchocerciasis

Mesh:

Substances:

Year:  2015        PMID: 26573416     DOI: 10.1016/j.bmcl.2015.10.037

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Metabolite profiling of infection-associated metabolic markers of onchocerciasis.

Authors:  Sasisekhar Bennuru; Sara Lustigman; David Abraham; Thomas B Nutman
Journal:  Mol Biochem Parasitol       Date:  2017-02-08       Impact factor: 1.759

2.  Lipid profiling of the filarial nematodes Onchocerca volvulus, Onchocerca ochengi and Litomosoides sigmodontis reveals the accumulation of nematode-specific ether phospholipids in the host.

Authors:  Vera Wewer; Benjamin L Makepeace; Vincent N Tanya; Helga Peisker; Kenneth Pfarr; Achim Hoerauf; Peter Dörmann
Journal:  Int J Parasitol       Date:  2017-07-23       Impact factor: 3.981

3.  Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG).

Authors:  Daniel Globisch; Lisa M Eubanks; Ryan J Shirey; Kenneth M Pfarr; Samuel Wanji; Alexander Y Debrah; Achim Hoerauf; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2017-05-29       Impact factor: 2.823

4.  Development and validation of an Onchocerca ochengi adult male worm gerbil model for macrofilaricidal drug screening.

Authors:  Fidelis Cho-Ngwa; Glory Enjong Mbah; Rene Bilingwe Ayiseh; Emmanuel Menang Ndi; Elvis Monya; Irene Memeh Tumanjong; Evans Ngandung Mainsah; Judy Sakanari; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2019-07-01

5.  Multimodal biomarker discovery for active Onchocerca volvulus infection.

Authors:  Ole Lagatie; Emmanuel Njumbe Ediage; Dirk Van Roosbroeck; Stijn Van Asten; Ann Verheyen; Linda Batsa Debrah; Alex Debrah; Maurice R Odiere; Ruben T'Kindt; Emmie Dumont; Koen Sandra; Lieve Dillen; Tom Verhaeghe; Rob Vreeken; Filip Cuyckens; Lieven J Stuyver
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29

6.  Whole blood transcriptome analysis in onchocerciasis.

Authors:  Ole Lagatie; Linda Batsa Debrah; Alex Y Debrah; Lieven J Stuyver
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2022-08-09

7.  Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study.

Authors:  Melissa Krizia Vieri; An Hotterbeekx; Michel Mandro; Joseph Nelson Siewe Fodjo; Alfred Dusabimana; Francoise Nyisi; Deby Mukendi; Joe Gwatsvaira; Samir Kumar-Singh; Robert Colebunders
Journal:  Pathogens       Date:  2021-06-08

8.  Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis.

Authors:  Ryan J Shirey; Daniel Globisch; Lisa M Eubanks; Mark S Hixon; Kim D Janda
Journal:  ACS Infect Dis       Date:  2018-09-21       Impact factor: 5.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.